These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15853561)

  • 1. Sumatriptan: a decade of use and experience in the treatment of migraine.
    Sheftell FD; Bigal ME; Tepper SJ; Rapoport AM
    Expert Rev Neurother; 2004 Mar; 4(2):199-209. PubMed ID: 15853561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumatriptan fast-disintegrating/rapid-release tablets in the acute treatment of migraine.
    Barbanti P; Le Pera D; Cruccu G
    Expert Rev Neurother; 2007 Aug; 7(8):927-34. PubMed ID: 17678486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute drug treatment of migraine attack.
    Narbone MC; Abbate M; Gangemi S
    Neurol Sci; 2004 Oct; 25 Suppl 3():S113-8. PubMed ID: 15549517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C; Maassen Van Den Brink A
    Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.
    Tfelt-Hansen P; Hougaard A
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):91-103. PubMed ID: 23228070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triptans.
    Bigal ME; Krymchantowski AV; Hargreaves R
    Expert Rev Neurother; 2009 May; 9(5):649-59. PubMed ID: 19402776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of migraine attacks. Pharmacological considerations].
    Salvesen R
    Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2176-9. PubMed ID: 8801661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
    Kato K
    No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
    Goldstein J; Silberstein SD; Saper JR; Elkind AH; Smith TR; Gallagher RM; Battikha JP; Hoffman H; Baggish J
    Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit.
    Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of sumatriptan in the treatment of migraine.
    Gross M
    Br J Clin Pract; 1993; 47(4):205-7. PubMed ID: 8260340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.